| PACKAGING TYPE: | 1x30 C-box |
| COMPOSITION: | Salmeterol(50mcg) & Fluticasone Propionate(500mcg) |
| FORMULATION: | Capsule |
| Description: | SALTEROL 500 Rotacap is a combination inhalation therapy containing Salmeterol 50 mcg, a long-acting beta-2 agonist (LABA), and Fluticasone Propionate 500 mcg, a corticosteroid. It is indicated for the maintenance treatment of moderate to severe asthma and chronic obstructive pulmonary disease (COPD). Salmeterol provides prolonged bronchodilation, helping to keep the airways open, while Fluticasone reduces airway inflammation. This higher-strength formulation ensures enhanced symptom control, improved lung function, and reduced risk of exacerbations, delivered via rotacap inhalation. |
| Side Effects: | Headache Tremors Palpitations Throat irritation Oral fungal infection (thrush) Rare: allergic reactions |
| How to Use: | Use with a compatible rotahaler device as prescribed Insert the rotacap into the inhaler device Inhale deeply through the mouthpiece Do not swallow the capsule Rinse mouth after use to prevent oral infections Follow proper inhalation technique |
| Precaution: | Rinse mouth after use to prevent oral infections Not for immediate relief of acute asthma attacks Use under medical supervision Avoid exceeding prescribed dosage Inform doctor about other medications or health conditions Regular monitoring required for long-term use |
| Product Benefits: | Provides long-lasting bronchodilation Strong anti-inflammatory action for better control Improves breathing and lung function Reduces frequency and severity of asthma attacks Helps prevent COPD exacerbations Targeted delivery through rotacap inhalati |
Frequently Asked Questions
It is used for maintenance treatment of moderate to severe asthma and COPD.
Salmeterol provides long-acting bronchodilation, while Fluticasone reduces airway inflammation.
SALTEROL 500 contains a higher dose of Fluticasone, offering stronger anti-inflammatory action for more severe conditions.










